Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
出版年份 2017 全文链接
标题
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-04-19
DOI
10.1038/srep46621
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial
- (2016) Guido J. H. Bastiaens et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01BWith Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP
- (2016) Tommy Rampling et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
- (2016) Muhammed O Afolabi et al. MOLECULAR THERAPY
- Protection against malaria at 1 year and immune correlates following PfSPZ vaccination
- (2016) Andrew S Ishizuka et al. NATURE MEDICINE
- Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I–III trials
- (2015) Selidji T Agnandji et al. Future Microbiology
- Tailoring a Combination Preerythrocytic Malaria Vaccine
- (2015) Karolis Bauza et al. INFECTION AND IMMUNITY
- Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults
- (2015) Caroline Ogwang et al. Science Translational Medicine
- Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production
- (2014) Mudassar Ahmad et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
- (2014) PLOS MEDICINE
- Malaria vaccine technology roadmap
- (2013) Vasee S Moorthy et al. LANCET
- Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine
- (2013) Margaret E McCoy et al. MALARIA JOURNAL
- Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults
- (2013) Caroline Ogwang et al. PLoS One
- The Relationship between RTS,S Vaccine-Induced Antibodies, CD4+ T Cell Responses and Protection against Plasmodium falciparum Infection
- (2013) Michael T. White et al. PLoS One
- Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
- (2013) R. A. Seder et al. SCIENCE
- Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
- (2013) George M Warimwe et al. Virology Journal
- Genetic engineering of attenuated malaria parasites for vaccination
- (2012) Shahid M Khan et al. CURRENT OPINION IN BIOTECHNOLOGY
- Full-Length Plasmodium falciparum Circumsporozoite Protein Administered with Long-Chain Poly(I·C) or the Toll-Like Receptor 4 Agonist Glucopyranosyl Lipid Adjuvant-Stable Emulsion Elicits Potent Antibody and CD4+T Cell Immunity and Protection in Mice
- (2012) Kathrin Kastenmüller et al. INFECTION AND IMMUNITY
- Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
- (2012) Geraldine A. O’Hara et al. JOURNAL OF INFECTIOUS DISEASES
- ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans
- (2012) Susanne H Sheehy et al. MOLECULAR THERAPY
- A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Mixed Adjuvant Formulations Reveal a New Combination That Elicit Antibody Response Comparable to Freund's Adjuvants
- (2012) Rachel P. J. Lai et al. PLoS One
- Protective Antibody and CD8+ T-Cell Responses to the Plasmodium falciparum Circumsporozoite Protein Induced by a Nanoparticle Vaccine
- (2012) Stephen A. Kaba et al. PLoS One
- A Statistical Interaction between Circumsporozoite Protein-Specific T Cell and Antibody Responses and Risk of Clinical Malaria Episodes following Vaccination with RTS,S/AS01E
- (2012) Francis M. Ndungu et al. PLoS One
- Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein
- (2012) Antu K. Dey et al. VACCINE
- The RTS,S vaccine candidate for malaria
- (2011) Jason A Regules et al. Expert Review of Vaccines
- Combining Liver- and Blood-Stage Malaria Viral-Vectored Vaccines: Investigating Mechanisms of CD8+ T Cell Interference
- (2011) E. K. Forbes et al. JOURNAL OF IMMUNOLOGY
- CD8+ T Effector Memory Cells Protect against Liver-Stage Malaria
- (2011) A. Reyes-Sandoval et al. JOURNAL OF IMMUNOLOGY
- Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa
- (2011) Amanda Leach et al. MALARIA JOURNAL
- Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-α Producing Effector and Central Memory CD4+ T Cells
- (2011) Joanne M. Lumsden et al. PLoS One
- Four year immunogenicity of the RTS,S/AS02A malaria vaccine in Mozambican children during a phase IIb trial
- (2011) Pedro Aide et al. VACCINE
- Prime-boost vectored malaria vaccines: Progress and prospects
- (2010) Adrian V. S. Hill et al. Human vaccines & immunotherapeutics
- Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines
- (2010) M. T. White et al. PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime–boost immunisation in non-human primates
- (2010) Stefania Capone et al. VACCINE
- Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8+ T-Cell Responses
- (2009) A. Reyes-Sandoval et al. INFECTION AND IMMUNITY
- Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
- (2009) Kent E. Kester et al. JOURNAL OF INFECTIOUS DISEASES
- Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
- (2009) Vasee S Moorthy et al. MALARIA JOURNAL
- Protection against a Malaria Challenge by Sporozoite Inoculation
- (2009) Meta Roestenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional immunoassays using an in-vitro malaria liver-stage infection model: where do we go from here?
- (2009) Brent L. House et al. TRENDS IN PARASITOLOGY
- From malaria control to eradication: The WHO perspective
- (2009) Kamini Mendis et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys
- (2009) S. Pichyangkul et al. VACCINE
- Antibodies to Pre‐erythrocyticPlasmodium falciparumAntigens and Risk of Clinical Malaria in Kenyan Children
- (2008) Chandy C. John et al. JOURNAL OF INFECTIOUS DISEASES
- What Should Vaccine Developers Ask? Simulation of the Effectiveness of Malaria Vaccines
- (2008) Melissa A. Penny et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now